Ghost Tree Capital as of Dec. 31, 2019
Portfolio Holdings for Ghost Tree Capital
Ghost Tree Capital holds 52 positions in its portfolio as reported in the December 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Spdr S&p 500 Etf (SPY) | 11.7 | $62M | 200k | 310.00 | |
| SPDR S&P Biotech (XBI) | 8.6 | $46M | 500k | 91.00 | |
| Ascendis Pharma A S (ASND) | 5.3 | $28M | 200k | 139.12 | |
| Constellation Pharmceticls I | 5.1 | $27M | 576k | 47.11 | |
| Sage Therapeutics Inc call | 4.3 | $23M | 150k | 150.00 | |
| Axsome Therapeutics (AXSM) | 3.9 | $21M | 200k | 103.36 | |
| Mirati Therapeutics | 3.7 | $19M | 150k | 128.86 | |
| Iovance Biotherapeutics (IOVA) | 3.4 | $18M | 650k | 27.68 | |
| Rocket Pharmaceuticals (RCKT) | 3.0 | $16M | 700k | 22.76 | |
| Reata Pharmaceuticals Inc Cl A | 2.9 | $15M | 75k | 204.43 | |
| Aerie Pharmaceuticals | 2.6 | $14M | 575k | 24.17 | |
| Adverum Biotechnologies | 2.6 | $14M | 1.2M | 11.52 | |
| Immunovant (IMVT) | 2.4 | $13M | 800k | 15.87 | |
| Amicus Therapeutics (FOLD) | 2.3 | $12M | 1.3M | 9.74 | |
| Aurinia Pharmaceuticals (AUPH) | 2.3 | $12M | 600k | 20.26 | |
| Blueprint Medicines (BPMC) | 2.3 | $12M | 150k | 80.11 | |
| Immunomedics | 2.0 | $11M | 500k | 21.16 | |
| Iovance Biotherapeutics Inc call | 2.0 | $11M | 350k | 30.00 | |
| BioCryst Pharmaceuticals (BCRX) | 2.0 | $10M | 3.0M | 3.45 | |
| Arvinas Ord (ARVN) | 1.8 | $9.2M | 225k | 41.09 | |
| Sarepta Therapeutics (SRPT) | 1.6 | $8.4M | 65k | 129.05 | |
| Dbv Technologies S A (DBVT) | 1.5 | $8.0M | 750k | 10.70 | |
| Momenta Pharmaceuticals | 1.5 | $7.9M | 400k | 19.73 | |
| Coherus Biosciences (CHRS) | 1.5 | $7.7M | 430k | 18.00 | |
| Apellis Pharmaceuticals Inc call | 1.4 | $7.5M | 250k | 30.00 | |
| Kalvista Pharmaceuticals (KALV) | 1.4 | $7.4M | 415k | 17.81 | |
| Myovant Sciences | 1.3 | $7.0M | 450k | 15.52 | |
| Iveric Bio | 1.2 | $6.4M | 750k | 8.58 | |
| Amarin Corp Plc option | 1.2 | $6.3M | 250k | 25.00 | |
| ArQule | 1.1 | $6.0M | 300k | 19.96 | |
| Fate Therapeutics (FATE) | 1.0 | $5.4M | 275k | 19.57 | |
| Apellis Pharmaceuticals (APLS) | 1.0 | $5.4M | 175k | 30.62 | |
| Viewray (VRAYQ) | 1.0 | $5.1M | 1.2M | 4.22 | |
| Invesco exchange traded (FXF) | 0.9 | $4.9M | 52k | 95.17 | |
| Insmed (INSM) | 0.9 | $4.8M | 200k | 23.88 | |
| Mersana Therapeutics (MRSN) | 0.9 | $4.6M | 800k | 5.73 | |
| Kiniksa Pharmaceuticals (KNSA) | 0.7 | $3.9M | 350k | 11.06 | |
| Apellis Pharmaceuticals Inc put | 0.7 | $3.8M | 300k | 12.50 | |
| Milestone Pharmaceuticals (MIST) | 0.7 | $3.8M | 235k | 16.01 | |
| Orchard Therapeutics Plc ads | 0.6 | $3.1M | 224k | 13.75 | |
| Selecta Biosciences (RNAC) | 0.5 | $2.7M | 1.2M | 2.38 | |
| Phasebio Pharmaceuticals (PHASQ) | 0.5 | $2.7M | 450k | 6.11 | |
| Global Blood Therapeutics In | 0.5 | $2.7M | 33k | 79.49 | |
| Biohaven Pharmaceutical Holding | 0.4 | $2.2M | 40k | 54.45 | |
| Chiasma | 0.4 | $2.1M | 425k | 4.96 | |
| Kadmon Hldgs | 0.4 | $2.1M | 463k | 4.53 | |
| Protagonist Therapeutics (PTGX) | 0.4 | $1.9M | 275k | 7.05 | |
| Invesco Currencyshares British Pound Sterling Trust etf (FXB) | 0.3 | $1.5M | 12k | 128.45 | |
| Karyopharm Therapeutics (KPTI) | 0.2 | $968k | 51k | 19.17 | |
| Tg Therapeutics (TGTX) | 0.1 | $699k | 63k | 11.10 | |
| Anaptysbio Inc Common (ANAB) | 0.0 | $187k | 12k | 16.26 | |
| Spectrum Pharmaceuticals | 0.0 | $140k | 38k | 3.65 |
